Holdings (Monthly)
Guide ↗
Biotechnology Ultrasector Profund
· ProFunds| # | Name | Ticker | Since | Shares | Value | % Port | Cat |
|---|---|---|---|---|---|---|---|
| 1 | N/A | N/A | Apr 2024 | 13,948,000 | $13.9M | 7.86% | RA |
| 2 | N/A | N/A | Apr 2024 | 11,158,000 | $11.2M | 6.29% | RA |
| 3 | N/A | N/A | Apr 2024 | 10,728,000 | $10.7M | 6.05% | RA |
| 4 | N/A | N/A | Apr 2024 | 6,007,000 | $6.0M | 3.39% | RA |
| 5 | N/A | N/A | Apr 2024 | 5,979,000 | $6.0M | 3.37% | RA |
| 6 | AGPXX | 825252885 | Apr 2024 | 4,141,972 | $4.1M | 2.34% | STIV |
| 7 | Moderna Inc | 60770K107 | Apr 2024 | 56,187 | $2.5M | 1.40% | EC |
| 8 | Mirum Pharmaceuticals Inc. | 604749101 | Apr 2024 | 20,449 | $2.1M | 1.19% | EC |
| 9 | Revolution Medicines Inc | 76155X100 | Apr 2024 | 20,967 | $2.0M | 1.15% | EC |
| 10 | Vaxcyte Inc | 92243G108 | Apr 2024 | 37,500 | $2.0M | 1.13% | EC |
| 11 | Amicus Therapeutics Inc. | 03152W109 | Apr 2024 | 138,235 | $2.0M | 1.11% | EC |
| 12 | Praxis Precision Medicines Inc | 74006W207 | Jan 2026 | 6,235 | $2.0M | 1.10% | EC |
| 13 | Alkermes PLC | G01767105 | Apr 2024 | 56,984 | $1.9M | 1.09% | EC |
| 14 | Gilead Sciences Inc. | 375558103 | Apr 2024 | 13,441 | $1.9M | 1.08% | EC |
| 15 | Krystal Biotech Inc | 501147102 | Apr 2024 | 6,803 | $1.9M | 1.07% | EC |
| 16 | Halozyme Therapeutics Inc | 40637H109 | Apr 2024 | 26,032 | $1.9M | 1.05% | EC |
| 17 | Amgen Inc. | 031162100 | Apr 2024 | 5,171 | $1.8M | 1.00% | EC |
| 18 | Celcuity Inc. | 15102K100 | Jan 2026 | 16,016 | $1.8M | 0.99% | EC |
| 19 | Roivant Sciences Ltd | G76279101 | Apr 2024 | 80,577 | $1.7M | 0.98% | EC |
| 20 | Bridgebio Pharma Inc | 10806X102 | Apr 2024 | 22,433 | $1.7M | 0.98% | EC |
| 21 | Vertex Pharmaceuticals Incorporated | 92532F100 | Apr 2024 | 3,668 | $1.7M | 0.97% | EC |
| 22 | Biomarin Pharmaceutical Inc. | 09061G101 | Apr 2024 | 30,370 | $1.7M | 0.97% | EC |
| 23 | Incyte Corporation. | 45337C102 | Apr 2024 | 17,136 | $1.7M | 0.97% | EC |
| 24 | Ionis Pharmaceuticals, Inc. | 462222100 | Apr 2024 | 20,741 | $1.7M | 0.97% | EC |
| 25 | Cytokinetics Inc | 23282W605 | Apr 2024 | 27,039 | $1.7M | 0.96% | EC |
| 26 | GRAIL Inc | 384747101 | Jan 2026 | 17,181 | $1.7M | 0.95% | EC |
| 27 | Regeneron Pharmaceuticals, Inc. | 75886F107 | Apr 2024 | 2,246 | $1.7M | 0.94% | EC |
| 28 | PTC Therapeutics, Inc. | 69366J200 | Apr 2024 | 22,009 | $1.7M | 0.94% | EC |
| 29 | Avidity Biosciences Inc. | 05370A108 | Apr 2024 | 22,857 | $1.7M | 0.94% | EC |
| 30 | Biogen Inc | 09062X103 | Apr 2024 | 9,185 | $1.7M | 0.93% | EC |
| 31 | Exact Sciences Corporation | 30063P105 | Apr 2024 | 16,107 | $1.6M | 0.93% | EC |
| 32 | Exelixis, Inc. | 30161Q104 | Apr 2024 | 39,710 | $1.6M | 0.93% | EC |
| 33 | Arrowhead Pharmaceuticals Inc | 04280A100 | Apr 2024 | 23,681 | $1.6M | 0.93% | EC |
| 34 | Natera Inc. | 632307104 | Apr 2024 | 6,996 | $1.6M | 0.91% | EC |
| 35 | AbbVie Inc. | 00287Y109 | Apr 2024 | 7,243 | $1.6M | 0.91% | EC |
| 36 | Scholar Rock Holding Corp. | 80706P103 | Apr 2024 | 36,201 | $1.6M | 0.90% | EC |
| 37 | Rhythm Pharmaceuticals Inc | 76243J105 | Apr 2024 | 15,566 | $1.6M | 0.90% | EC |
| 38 | United Therapeutics Corporation | 91307C102 | Apr 2024 | 3,364 | $1.6M | 0.89% | EC |
| 39 | TG Therapeutics Inc | 88322Q108 | Apr 2024 | 53,297 | $1.6M | 0.88% | EC |
| 40 | CG Oncology Inc. | 156944100 | Jan 2026 | 29,731 | $1.5M | 0.87% | EC |
| 41 | Travere Therapeutics Inc | 89422G107 | Apr 2024 | 47,437 | $1.5M | 0.83% | EC |
| 42 | Protagonist Therapeutics Inc | 74366E102 | Apr 2024 | 17,847 | $1.5M | 0.82% | EC |
| 43 | Madrigal Pharmaceuticals Inc | 558868105 | Apr 2024 | 2,952 | $1.4M | 0.81% | EC |
| 44 | Neurocrine Biosciences Inc | 64125C109 | Apr 2024 | 10,479 | $1.4M | 0.80% | EC |
| 45 | CRISPR Therapeutics AG | H17182108 | Apr 2024 | 28,319 | $1.4M | 0.80% | EC |
| 46 | Adma Biologics Inc | 000899104 | Apr 2024 | 81,625 | $1.4M | 0.80% | EC |
| 47 | Acadia Pharmaceuticals Inc | 004225108 | Apr 2024 | 55,582 | $1.4M | 0.79% | EC |
| 48 | Beam Therapeutics Inc. | 07373V105 | Apr 2024 | 49,582 | $1.4M | 0.77% | EC |
| 49 | Alnylam Pharmaceuticals Inc. | 02043Q107 | Apr 2024 | 4,032 | $1.4M | 0.77% | EC |
| 50 | Insmed Inc | 457669307 | Apr 2024 | 8,590 | $1.3M | 0.76% | EC |
| 51 | Arcellx Inc | 03940C100 | Apr 2024 | 19,488 | $1.3M | 0.75% | EC |
| 52 | Nuvalent Inc | 670703107 | Apr 2024 | 12,881 | $1.3M | 0.75% | EC |
| 53 | Twist Bioscience Corporation | 90184D100 | Apr 2024 | 32,028 | $1.3M | 0.74% | EC |
| 54 | Viking Therapeutics Inc. | 92686J106 | Apr 2024 | 43,455 | $1.3M | 0.71% | EC |
| 55 | Arcutis Biotherapeutics Inc. | 03969K108 | Apr 2024 | 48,238 | $1.2M | 0.69% | EC |
| 56 | Kymera Therapeutics Inc | 501575104 | Apr 2024 | 16,443 | $1.2M | 0.67% | EC |
| 57 | Dyne Therapeutics Inc. | 26818M108 | Apr 2024 | 65,698 | $1.2M | 0.66% | EC |
| 58 | Summit Therapeutics Inc. | 86627T108 | Apr 2024 | 80,686 | $1.2M | 0.66% | EC |
| 59 | Denali Therapeutics Inc | 24823R105 | Apr 2024 | 53,705 | $1.2M | 0.66% | EC |
| 60 | IDEAYA Biosciences Inc. | 45166A102 | Apr 2024 | 35,425 | $1.1M | 0.64% | EC |
| 61 | Recursion Pharmaceuticals Inc | 75629V104 | Apr 2024 | 271,602 | $1.1M | 0.64% | EC |
| 62 | Cogent Biosciences Inc. | 19240Q201 | Apr 2024 | 31,144 | $1.1M | 0.63% | EC |
| 63 | Sarepta Therapeutics Inc | 803607100 | Apr 2024 | 54,739 | $1.1M | 0.63% | EC |
| 64 | Mineralys Therapeutics Inc. | 603170101 | Jan 2026 | 35,860 | $1.1M | 0.62% | EC |
| 65 | Apellis Pharmaceuticals Inc | 03753U106 | Apr 2024 | 48,067 | $1.1M | 0.61% | EC |
| 66 | ImmunityBio Inc | 45256X103 | Apr 2024 | 170,262 | $1.1M | 0.60% | EC |
| 67 | Ultragenyx Pharmaceuticals Inc | 90400D108 | Apr 2024 | 44,032 | $1.1M | 0.60% | EC |
| 68 | Catalyst Pharmaceuticals Inc. | 14888U101 | Apr 2024 | 43,464 | $1.1M | 0.60% | EC |
| 69 | Uniqure N.V. | N90064101 | Jan 2026 | 46,240 | $1.1M | 0.59% | EC |
| 70 | Vera Therapeutics Inc. | 92337R101 | Apr 2024 | 24,064 | $1.0M | 0.59% | EC |
| 71 | Soleno Therapeutics Inc | 834203309 | Apr 2024 | 26,800 | $1.0M | 0.58% | EC |
| 72 | Immunovant Inc | 45258J102 | Apr 2024 | 37,102 | $965K | 0.54% | EC |
| 73 | Viridian Therapeutics Inc | 92790C104 | Apr 2024 | 27,964 | $923K | 0.52% | EC |
| 74 | Syndax Pharmaceuticals Inc. | 87164F105 | Apr 2024 | 45,401 | $922K | 0.52% | EC |
| 75 | Veracyte Inc | 92337F107 | Apr 2024 | 24,212 | $922K | 0.52% | EC |
| 76 | Apogee Therapeutics Inc. | 03770N101 | Apr 2024 | 13,630 | $893K | 0.50% | EC |
| 77 | Dianthus Therapeutics Inc | 252828108 | Jan 2026 | 16,225 | $866K | 0.49% | EC |
| 78 | Ardelyx Inc | 039697107 | Apr 2024 | 109,395 | $841K | 0.47% | EC |
| 79 | Agios Pharmaceuticals Inc | 00847X104 | Apr 2024 | 30,134 | $827K | 0.47% | EC |
| 80 | Novavax Inc | 670002401 | Apr 2024 | 92,370 | $817K | 0.46% | EC |
| 81 | Dynavax Technologies Corp. | 268158201 | Apr 2024 | 51,561 | $798K | 0.45% | EC |
| 82 | Intellia Therapeutics Inc | 45826J105 | Apr 2024 | 60,394 | $794K | 0.45% | EC |
| 83 | Celldex Therapeutics Inc. | 15117B202 | Apr 2024 | 32,024 | $788K | 0.44% | EC |
| 84 | Immunome Inc | 45257U108 | Jan 2026 | 31,790 | $783K | 0.44% | EC |
| 85 | Disc Medicine Inc | 254604101 | Apr 2024 | 10,119 | $782K | 0.44% | EC |
| 86 | Stoke Therapeutics Inc | 86150R107 | Jan 2026 | 25,285 | $767K | 0.43% | EC |
| 87 | Vericel Corporation | 92346J108 | Apr 2024 | 21,193 | $763K | 0.43% | EC |
| 88 | Tango Therapeutics Inc. | 87583X109 | Apr 2024 | 63,527 | $738K | 0.42% | EC |
| 89 | Mannkind Corporation | 56400P706 | Apr 2024 | 126,848 | $733K | 0.41% | EC |
| 90 | BioCryst Pharmaceuticals Inc. | 09058V103 | Apr 2024 | 107,248 | $706K | 0.40% | EC |
| 91 | Biohaven Ltd | G1110E107 | Apr 2024 | 58,678 | $694K | 0.39% | EC |
| 92 | Janux Therapeutics Inc | 47103J105 | Jan 2026 | 49,130 | $674K | 0.38% | EC |
| 93 | Corvus Pharmaceuticals Inc | 221015100 | Jan 2026 | 27,957 | $579K | 0.33% | EC |
| 94 | Arcus Biosciences Inc. | 03969F109 | Apr 2024 | 26,052 | $548K | 0.31% | EC |
| 95 | RAPT Therapeutics Inc. | 75382E208 | Jan 2026 | 9,247 | $533K | 0.30% | EC |
| 96 | Caredx Inc | 14167L103 | Apr 2024 | 25,549 | $525K | 0.30% | EC |
| 97 | ORIC Pharmaceuticals Inc. | 68622P109 | Apr 2024 | 49,671 | $510K | 0.29% | EC |
| 98 | Iovance Biotherapeutics Inc | 462260100 | Apr 2024 | 198,050 | $505K | 0.28% | EC |
| 99 | Day One Biopharmaceuticals Inc. | 23954D109 | Apr 2024 | 44,017 | $491K | 0.28% | EC |
| 100 | Spyre Therapeutics Inc | 00773J202 | Jan 2026 | 14,973 | $479K | 0.27% | EC |
| 101 | Precigen Inc | 74017N105 | Jan 2026 | 104,906 | $471K | 0.27% | EC |
| 102 | AnaptysBio Inc. | 032724106 | Apr 2024 | 9,899 | $469K | 0.26% | EC |
| 103 | Cytomx Therapeutics Inc | 23284F105 | Jan 2026 | 76,698 | $436K | 0.25% | EC |
| 104 | Taysha Gene Therapies Inc. | 877619106 | Jan 2026 | 96,659 | $436K | 0.25% | EC |
| 105 | Kura Oncology Inc. | 50127T109 | Apr 2024 | 52,534 | $427K | 0.24% | EC |
| 106 | Rigel Pharmaceuticals Inc. | 766559702 | Jan 2026 | 12,082 | $421K | 0.24% | EC |
| 107 | Nurix Therapeutics Inc. | 67080M103 | Apr 2024 | 25,375 | $419K | 0.24% | EC |
| 108 | Relay Therapeutics Inc | 75943R102 | Apr 2024 | 54,319 | $416K | 0.23% | EC |
| 109 | Monte Rosa Therapeutics Inc | 61225M102 | Jan 2026 | 18,906 | $388K | 0.22% | EC |
| 110 | Erasca Inc | 29479A108 | Jan 2026 | 36,680 | $386K | 0.22% | EC |
| 111 | Kodiak Sciences Inc | 50015M109 | Jan 2026 | 16,686 | $380K | 0.21% | EC |
| 112 | Oruka Therapeutics Inc | 687604108 | Jan 2026 | 10,789 | $369K | 0.21% | EC |
| 113 | Sana Biotechnology Inc | 799566104 | Apr 2024 | 76,860 | $340K | 0.19% | EC |
| 114 | Palvella Therapeutics Inc. | 697947109 | Jan 2026 | 4,413 | $338K | 0.19% | EC |
| 115 | Upstream Bio Inc | 91678A107 | Jan 2026 | 10,845 | $337K | 0.19% | EC |
| 116 | Xencor Inc | 98401F105 | Apr 2024 | 27,403 | $331K | 0.19% | EC |
| 117 | Olema Pharmaceuticals Inc. | 68062P106 | Apr 2024 | 12,617 | $325K | 0.18% | EC |
| 118 | ARS Pharmaceuticals Inc | 82835W108 | Apr 2024 | 32,398 | $324K | 0.18% | EC |
| 119 | Geron Corp. | 374163103 | Apr 2024 | 230,413 | $316K | 0.18% | EC |
| 120 | Altimmune Inc. | 02155H200 | Apr 2024 | 54,882 | $307K | 0.17% | EC |
| 121 | Sionna Therapeutics Inc. | 829401108 | Jan 2026 | 6,922 | $293K | 0.16% | EC |
| 122 | KalVista Pharmaceuticals Inc. | 483497103 | Jan 2026 | 18,388 | $287K | 0.16% | EC |
| 123 | Emergent Biosolutions Inc | 29089Q105 | Jan 2026 | 24,956 | $283K | 0.16% | EC |
| 124 | Bicara Therapeutics Inc. | 055477103 | Jan 2026 | 16,749 | $281K | 0.16% | EC |
| 125 | VIR Biotechnology Inc | 92764N102 | Apr 2024 | 37,500 | $279K | 0.16% | EC |
| 126 | Replimune Group Inc | 76029N106 | Apr 2024 | 39,527 | $278K | 0.16% | EC |
| 127 | Compass Therapeutics Inc | 20454B104 | Jan 2026 | 42,540 | $272K | 0.15% | EC |
| 128 | Annexon Inc | 03589W102 | Jan 2026 | 39,710 | $248K | 0.14% | EC |
| 129 | Myriad Genetics Inc. | 62855J104 | Apr 2024 | 41,835 | $235K | 0.13% | EC |
| 130 | Verastem Inc | 92337C203 | Jan 2026 | 36,258 | $221K | 0.12% | EC |
| 131 | Lexeo Therapeutics Inc | 52886X107 | Jan 2026 | 28,639 | $212K | 0.12% | EC |
| 132 | 4D Molecular Therapeutics Inc | 35104E100 | Apr 2024 | 23,384 | $207K | 0.12% | EC |
| 133 | Cullinan Therapeutics Inc | 230031106 | Apr 2024 | 17,290 | $207K | 0.12% | EC |
| 134 | Anavex Life Sciences Corp. | 032797300 | Apr 2024 | 43,818 | $206K | 0.12% | EC |
| 135 | Prothena Corporation PLC | G72800108 | Apr 2024 | 23,144 | $204K | 0.11% | EC |
| 136 | Prime Medicine Inc | 74168J101 | Jan 2026 | 52,624 | $200K | 0.11% | EC |
| 137 | Gossamer Bio Inc | 38341P102 | Jan 2026 | 87,693 | $200K | 0.11% | EC |
| 138 | Akebia Therapeutics Inc. | 00972D105 | Jan 2026 | 139,787 | $197K | 0.11% | EC |
| 139 | Regenxbio Inc. | 75901B107 | Apr 2024 | 16,596 | $185K | 0.10% | EC |
| 140 | Inhibrx Biosciences Inc. | 45720N103 | Jan 2026 | 2,406 | $184K | 0.10% | EC |
| 141 | ArriVent BioPharma Inc. | 04272N102 | Jan 2026 | 8,096 | $182K | 0.10% | EC |
| 142 | Absci Corp. | 00091E109 | Jan 2026 | 57,421 | $172K | 0.10% | EC |
| 143 | Immuneering Corp. | 45254E107 | Jan 2026 | 36,653 | $170K | 0.10% | EC |
| 144 | Keros Therapeutics Inc. | 492327101 | Apr 2024 | 8,488 | $152K | 0.09% | EC |
| 145 | Invivyd Inc | 00534A102 | Jan 2026 | 79,776 | $139K | 0.08% | EC |
| 146 | Savara Inc | 805111101 | Jan 2026 | 25,191 | $136K | 0.08% | EC |
| 147 | Arbutus Biopharma Corp. | 03879J100 | Jan 2026 | 32,809 | $136K | 0.08% | EC |
| 148 | Tyra Biosciences Inc | 90240B106 | Jan 2026 | 4,333 | $134K | 0.08% | EC |
| 149 | Rezolute Inc | 76200L309 | Jan 2026 | 39,079 | $131K | 0.07% | EC |
| 150 | MiMedx Group Inc. | 602496101 | Apr 2024 | 19,429 | $99K | 0.06% | EC |
| 151 | Ironwood Pharmaceuticals, Inc. | 46333X108 | Apr 2024 | 18,178 | $89K | 0.05% | EC |
| 152 | N/A | N/A | Apr 2024 | -590 | $45K | 0.03% | DE |
| 153 | N/A | N/A | Apr 2024 | 9,511 | $6K | 0.00% | — |
| 154 | N/A | N/A | Apr 2024 | -30 | $5K | 0.00% | DE |
| 155 | N/A | N/A | Apr 2024 | 6,864 | $-1830393 | -1.03% | DE |
| 156 | N/A | N/A | Apr 2024 | 7,243 | $-1927428 | -1.09% | DE |